Related references
Note: Only part of the references are listed.Multifunctional Graphene Oxide-based Triple Stimuli-Responsive Nanotheranostics
Yu Chen et al.
ADVANCED FUNCTIONAL MATERIALS (2014)
Molecule Drugs for Enhanced Therapeutic Efficacy
Tianyue Jiang et al.
ADVANCED FUNCTIONAL MATERIALS (2014)
Effect of Furin inhibitor on lung adenocarcinoma cell growth and metastasis
Yong-Chao Ma et al.
CANCER CELL INTERNATIONAL (2014)
Stimuli-responsive nanomaterials for therapeutic protein delivery
Yue Lu et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Cocoon-Like Self-Degradable DNA Nanoclew for Anticancer Drug Delivery
Wujin Sun et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Recent progress in multidrug delivery to cancer cells by liposomes
Ran Mo et al.
NANOMEDICINE (2014)
Enzyme-responsive nanomaterials for controlled drug delivery
Quanyin Hu et al.
NANOSCALE (2014)
Advances in Anticancer Protein Delivery using Micro-/Nanoparticles
Wujin Sun et al.
PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION (2014)
TRAIL-coated leukocytes that kill cancer cells in the circulation
Michael J. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Smart pH-Responsive Nanocarriers Based on Nano-Graphene Oxide for Combined Chemo- and Photothermal Therapy Overcoming Drug Resistance
Liangzhu Feng et al.
ADVANCED HEALTHCARE MATERIALS (2014)
Tumor-Targeting and Microenvironment-Responsive Smart Nanoparticles for Combination Therapy of Antiangiogenesis and Apoptosis
Shixian Huang et al.
ACS NANO (2013)
Novel Conjugation of Tumor-Necrosis-Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Monomethyl Auristatin E for Efficient Antitumor Drug Delivery
Li-Qiang Pan et al.
ADVANCED MATERIALS (2013)
Orthogonal Adsorption Onto Nano-Graphene Oxide Using Different Intermolecular Forces for Multiplexed Delivery
Feng Wang et al.
ADVANCED MATERIALS (2013)
Doxorubicin-loaded porous PLGA microparticles with surface attached TRAIL for the inhalation treatment of metastatic lung cancer
Insoo Kim et al.
BIOMATERIALS (2013)
Nano-graphene in biomedicine: theranostic applications
Kai Yang et al.
CHEMICAL SOCIETY REVIEWS (2013)
Biocompatibility of engineered nanoparticles for drug delivery
Sheva Naahidi et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Preparation and functionalization of graphene nanocomposites for biomedical applications
Kai Yang et al.
NATURE PROTOCOLS (2013)
Cancer Nanomedicine: From Drug Delivery to Imaging
Edward Kai-Hua Chow et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Controlled intracellular self-assembly of gadolinium nanoparticles as smart molecular MR contrast agents
Chun-Yan Cao et al.
SCIENTIFIC REPORTS (2013)
Successful Stabilization of Graphene Oxide in Electrolyte Solutions: Enhancement of Biofunctionalization and Cellular Uptake
Bong Jin Hong et al.
ACS NANO (2012)
PSMA-Targeted Theranostic Nanoplex for Prostate Cancer Therapy
Zhihang Chen et al.
ACS NANO (2012)
Engineering Inorganic Nanoemulsions/Nanoliposomes by Fluoride-Silica Chemistry for Efficient Delivery/Co-Delivery of Hydrophobic Agents
Yu Chen et al.
ADVANCED FUNCTIONAL MATERIALS (2012)
Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types
Sungho Bae et al.
BIOMATERIALS (2012)
Combinatorial drug therapy for cancer in the post-genomic era
Bissan Al-Lazikani et al.
NATURE BIOTECHNOLOGY (2012)
Endoprotease-Mediated Intracellular Protein Delivery Using Nanocapsules
Anuradha Biswas et al.
ACS NANO (2011)
DNA-Directed Self-Assembly of Graphene Oxide with Applications to Ultrasensitive Oligonucleotide Assay
Longhua Tang et al.
ACS NANO (2011)
Graphene Oxide-Peptide Conjugate as an Intracellular Protease Sensor for Caspase-3 Activation Imaging in Live Cells
Haibo Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Down-regulation of HSP27 sensitizes TRAIL-resistant tumor cell to TRAIL-induced apoptosis
Hongqin Zhuang et al.
LUNG CANCER (2010)
Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy
Nagesh Kolishetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Functional Graphene Oxide as a Nanocarrier for Controlled Loading and Targeted Delivery of Mixed Anticancer Drugs
Liming Zhang et al.
SMALL (2010)
Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid Tumors
Gerald Batist et al.
CLINICAL CANCER RESEARCH (2009)
Cationic Liposomes Loaded with Proapoptotic Peptide D-(KLAKLAK)2 and Bcl-2 Antisense Oligodeoxynucleotide G3139 for Enhanced Anticancer Therapy
Young Tag Ko et al.
MOLECULAR PHARMACEUTICS (2009)
PEGylated nanographene oxide for delivery of water-insoluble cancer drugs
Zhuang Liu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Nano-Graphene Oxide for Cellular Imaging and Drug Delivery
Xiaoming Sun et al.
NANO RESEARCH (2008)
The TRAIL apoptotic pathway in cancer onset, progression and therapy
Ricky W. Johnstone et al.
NATURE REVIEWS CANCER (2008)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
Lipid rafts and nonrafts mediate tumor necrosis factor-related apoptosis-inducing ligand-induced apoptotic and nonapoptotic signals in non-small cell lung carcinoma cells
Jin H. Song et al.
CANCER RESEARCH (2007)
Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis
Susan L. Kohlhaas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice
Lawrence D. Mayer et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Caspases 3 and 7: Key mediators of mitochondrial events of apoptosis
SA Lakhani et al.
SCIENCE (2006)
Proprotein convertases: Master switches in the regulation of tumor growth and progression
DE Bassi et al.
MOLECULAR CARCINOGENESIS (2005)
Tumor necrosis factor, cancer and anticancer therapy
S Mocellin et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Prognostic significance of Fas (CD95) and TRAIL receptors (DR4/DR5) expression in acute myelogenous leukemia
YJ Min et al.
LEUKEMIA RESEARCH (2004)
Cytokines in cancer pathogenesis and cancer therapy
G Dranoff
NATURE REVIEWS CANCER (2004)
Adenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effect
JY Seol et al.
CANCER GENE THERAPY (2003)
Furin at the cutting edge: From protein traffic to embryogenesis and disease
G Thomas
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL
SB Gibson et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
